+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Skin Cancer Drugs Market Research Reports

From
From
From
KEYTRUDA Market Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

KEYTRUDA Market Drug Insight and Market Forecast - 2032

  • Report
  • February 2023
  • 30 Pages
  • Global
From
From
Opdualag (Nivolumab and Relatlimab) Drug Insight and Market Forecast - 2035 - Product Thumbnail Image

Opdualag (Nivolumab and Relatlimab) Drug Insight and Market Forecast - 2035

  • Drug Pipelines
  • December 2022
  • 30 Pages
  • Global
From
From
From
Global Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2022 - Product Thumbnail Image

Global Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2022

  • Clinical Trials
  • August 2022
  • 150 Pages
  • Global
From
From
From
BRAF-Mutant Metastatic Melanoma - Epidemiology Forecast to 2032 - Product Thumbnail Image

BRAF-Mutant Metastatic Melanoma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Gorlin Syndrome - Epidemiology Forecast to 2032 - Product Thumbnail Image

Gorlin Syndrome - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Basal Cell Neoplasms - Epidemiology Forecast to 2032 - Product Thumbnail Image

Basal Cell Neoplasms - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Actinic Keratosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Actinic Keratosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
Loading Indicator

The Skin Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat skin cancer. These drugs are used to treat a variety of skin cancer types, including melanoma, basal cell carcinoma, and squamous cell carcinoma. The drugs are typically administered orally, intravenously, or topically. The market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Novartis, Pfizer, and Roche. These companies are constantly researching and developing new treatments to improve the efficacy of existing treatments and to develop new treatments for skin cancer. In addition to the major players, there are also many smaller companies that are developing treatments for skin cancer. These companies are often focused on developing treatments for rarer forms of skin cancer, such as Merkel cell carcinoma. Examples of these companies include Aduro Biotech, Arcutis Biotherapeutics, and OncoSec Medical. Show Less Read more